Takeda, Molecular Templates Partner to Develop Next-generation IO for Multiple Myeloma
News
Molecular Templates has partnered with Takeda to develop engineered toxin bodies (EBTs) — a next-generation immuno-oncology therapy that delivers toxic payloads to cancer cells — targeting the CD38 molecule as a potential treatment for multiple myeloma. ... Read more